Prostaglandin-endoperoxide synthase genes COX1 and COX2 - novel modifiers of disease severity in cystic fibrosis patients (Q42933511)

11 November 2017

title

Prostaglandin-endoperoxide synthase genes COX1 and COX2 - novel modifiers of disease severity in cystic fibrosis patients (English)

1 reference

11 November 2017

0 references

7

1 reference

11 November 2017

10

J Bal

1 reference

11 November 2017

K Czerska

1

1 reference

11 November 2017

A Sobczynska-Tomaszewska

2

1 reference

11 November 2017

D Sands

3

1 reference

11 November 2017

A Nowakowska

4

1 reference

11 November 2017

D Bak

5

1 reference

11 November 2017

K Wertheim

6

1 reference

11 November 2017

J Zielenski

8

1 reference

11 November 2017

A Norek

9

1 reference

11 November 2017

publication date

1 January 2010

1 reference

Journal of Applied Genetics

11 November 2017

published in

1 reference

11 November 2017

volume

51

1 reference

11 November 2017

issue

3

1 reference

11 November 2017

page(s)

323-330

1 reference

Strategies for identifying modifier genes in cystic fibrosis

11 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03208862

COX-2: a link between airway inflammation and disordered chloride secretion in cystic fibrosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03208862

Modifier genetics: cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03208862

Modifier genes in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03208862

Modifier genes and variation in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03208862

Finding genetic modifiers of cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03208862

Beta-defensin genomic copy number is not a modifier locus for cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03208862

Contribution of genetic factors other than CFTR to disease severity in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03208862

Disease severity in siblings with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03208862

Gene modifiers of lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03208862

Effect of high-dose ibuprofen in patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03208862

Clinical use of Ibuprofen is associated with slower FEV1 decline in children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03208862

Cyclooxygenase-1 haplotype modulates platelet response to aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03208862

Aspirin resistance: an evaluation of current evidence and measurement methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03208862

Modifier genes in cystic fibrosis lung disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03208862

A simple salting out procedure for extracting DNA from human nucleated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03208862

Upregulation of COX-1 and COX-2 in nasal polyps in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03208862

Association of COX-2 gene haplotypes with prostaglandins production in bronchial asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03208862

Disease modifying genes in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03208862

The role of COX-1 and COX-2 in asthma pathogenesis and its significance in the use of selective inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03208862

Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03208862

Cyclooxygenase 1 (COX1) polymorphisms in African-American and Caucasian populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03208862

Heritability of lung disease severity in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03208862

The genesis of cystic fibrosis lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03208862

Cystic fibrosis: genotypic and phenotypic variations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03208862

A genetic polymorphism in prostaglandin synthase 2 (8473, T→C) and the risk of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03208862

Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03208862

Association of tumour necrosis factor alpha variants with the CF pulmonary phenotype

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

Polymorphisms in PTGS1 (=COX-1) and risk of colorectal polyps

1 reference

12 December 2020

Functional characterization of cyclooxygenase-2 polymorphisms.

1 reference

12 December 2020

Genetic modifiers of lung disease in cystic fibrosis

1 reference

12 December 2020

Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response.

1 reference

12 December 2020

Genotype-phenotype correlation in cystic fibrosis: the role of modifier genes.

1 reference

12 December 2020

1 reference

12 December 2020

Cystic fibrosis modifier genes

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03208862

1 reference

11 November 2017

1 reference